Kraematon Investment Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-9,815
| Closed | -$220K | – | 88 |
|
|
2024
Q2 | $220K | Hold |
9,815
| – | – | 0.22% | 78 |
|
|
2024
Q1 | $270K | Sell |
9,815
-875
| -8% | -$24.1K | 0.27% | 73 |
|
|
2023
Q4 | $326K | Sell |
10,690
-840
| -7% | -$25.6K | 0.36% | 64 |
|
|
2023
Q3 | $365K | Sell |
11,530
-1,000
| -8% | -$31.6K | 0.45% | 56 |
|
|
2023
Q2 | $511K | Buy |
12,530
+4,150
| +50% | +$169K | 0.56% | 52 |
|
|
2023
Q1 | $312K | Buy |
8,380
+2,750
| +49% | +$102K | 0.36% | 61 |
|
|
2022
Q4 | $196K | Sell |
5,630
-160
| -3% | -$5.58K | 0.21% | 83 |
|
|
2022
Q3 | $324K | Sell |
5,790
-350
| -6% | -$19.6K | 0.42% | 59 |
|
|
2022
Q2 | $318K | Hold |
6,140
| – | – | 0.37% | 60 |
|
|
2022
Q1 | $446K | Buy |
6,140
+15
| +0.2% | +$1.09K | 0.42% | 58 |
|
|
2021
Q4 | $724K | Buy |
+6,125
| New | +$724K | 0.65% | 44 |
|